K02288

Overview

K02288 is a potent bone morphogenetic protein (BMP) type I receptor inhibitor with IC 50 s of 1.8, 1.1, 6.4 nM for ALK1 , ALK2 and ALK6 , respectively. K02288 shows slightly weaker inhibition against ALK3 and ALK6 with IC 50 s of of 5-34 nM.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Obesity | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Others | Products > Signaling Pathways > TGF-β Receptor

Product Information

• Catalog No.: HY-12278
• CAS No.: 1431985-92-0
• Molecular Formula: C20H20N2O4
• Molecular Weight: 352.38
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (7.09 mM); Clear solution
• Availability: In-stock

Source

Original product source